Biopharma Products
For GB healthcare professionals only. This content contains promotional and brand information.
Idacio® (adalimumab) and Tyenne▼(tocilizumab) prescribing information is available on the download links below. Adverse event reporting details are available at the bottom of this webpage.
Idacio Prescribing Information
- Filename
- idacioprescribinginformation2024.pdf
- Size
- 1 MB
- Format
Tyenne Prescribing Information
Tyenne Prescribing Information
- Filename
- Tyenne Prescribing Information September 2023.pdf
- Size
- 2 MB
- Format
Adverse events should be reported. Reporting forms and information can be found at: https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Ltd. Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT Tel +44 (0)1928 533 575. Email: pharmacovigilance.gb@fresenius-kabi.com
GB--2400015 October 2024